Cardiac allograft vasculopathy screening: Difference between revisions
Created page with "__NOTOC__ {{Cardiac allograft vasculopathy}} {{CMG}}; {{AE}} {{AN}} {{RT}} ==Overview== In most cardiac transplant centers coronary angiography currently remains the screenin..." |
|||
| Line 7: | Line 7: | ||
==Screening== | ==Screening== | ||
The 2010 International Society of Heart and Lung Transplant Guidelines for the care of heart transplant recipients | The 2010 International Society of Heart and Lung Transplant Guidelines for the care of heart transplant recipients recommend annual invasive coronary angiography as the screening tool of choice for CAV.<ref name="pmid20643330">{{cite journal| author=Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S et al.| title=The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. | journal=J Heart Lung Transplant | year= 2010 | volume= 29 | issue= 8 | pages= 914-56 | pmid=20643330 | doi=10.1016/j.healun.2010.05.034 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20643330 }} </ref> | ||
==References== | ==References== | ||
Revision as of 15:07, 27 July 2014
|
Cardiac allograft vasculopathy Microchapters |
|
Differentiating Cardiac allograft vasculopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cardiac allograft vasculopathy screening On the Web |
|
American Roentgen Ray Society Images of Cardiac allograft vasculopathy screening |
|
Directions to Hospitals Treating Cardiac allograft vasculopathy |
|
Risk calculators and risk factors for Cardiac allograft vasculopathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2] Raviteja Guddeti, M.B.B.S. [3]
Overview
In most cardiac transplant centers coronary angiography currently remains the screening tool of choice for cardiac allograft vasculopathy (CAV).
Screening
The 2010 International Society of Heart and Lung Transplant Guidelines for the care of heart transplant recipients recommend annual invasive coronary angiography as the screening tool of choice for CAV.[1]
References
- ↑ Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S; et al. (2010). "The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients". J Heart Lung Transplant. 29 (8): 914–56. doi:10.1016/j.healun.2010.05.034. PMID 20643330.